Carl Anthony Evans

Insider Reports History

Location
Houston, TX
Signature
/s/ Christopher Downs, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carl Anthony Evans:

Company Role Class Num Shares Value Price $ Report Date Ownership
CNS Pharmaceuticals, Inc. Director Restricted Stock Units 147,094 $44,128 $0.3000 08 Apr 2024 Direct
CNS Pharmaceuticals, Inc. Director Common stock 33,458 $10,037 $0.3000 01 Feb 2024 Direct
CNS Pharmaceuticals, Inc. Director Option to purchase common stock 129,594 08 Apr 2024 Direct
CNS Pharmaceuticals, Inc. Director Series B Warrant to purchase common stock 112,094 01 Feb 2024 Direct
CNS Pharmaceuticals, Inc. Director Series A Warrant to purchase common stock 78,761 01 Feb 2024 Direct

Insider Reports Filed by Carl Anthony Evans

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CNSP CNS Pharmaceuticals, Inc. 08 Apr 2024 2 $0 4 Director 10 Apr 2024, 21:52
CNSP CNS Pharmaceuticals, Inc. 01 Feb 2024 3 +$10,000 4 Director 06 Feb 2024, 10:27
CNSP CNS Pharmaceuticals, Inc. 21 Sep 2023 1 $0 4/A Director 12 Oct 2023, 18:01
CNSP CNS Pharmaceuticals, Inc. 08 Mar 2022 1 +$1,005 4 Director 09 Mar 2022, 13:34
CNSP CNS Pharmaceuticals, Inc. 15 Jul 2021 1 $0 4 Director 16 Jul 2021, 17:00